Dialysis Market

Global Dialysis Market Size (2023 to 2028)

The global dialysis market is estimated to be worth USD 170.17 billion by 2028 from USD 114.96 billion in 2023, registering a CAGR of 8.16% during the forecast period.

Dialysis is a process that removes waste products and excess fluids from the blood when the kidney stops working. As a result, dialysis increases the life span of kidney-affected patients. Usually, life expectance with the process may vary from person to person between 5-10 years, and some patients have lived up to 30 years with the assistance of dialysis.

MARKET DRIVERS: 

The growing patient population suffering from kidney failure and ESRD is primarily accelerating the growth of the dialysis market across the world.

The prevalence of kidney failure and end-stage renal disease (ESRD) has exploded in intensive care units in hospitals around the world, creating a worrying shortage of dialysis machines and even dialysis solutions. The disease is spreading rapidly in more than 99 countries around the world. Worldwide, approximately 2 million people are affected by ESRD each year. In addition, the growing geriatric population is increasing the number of older people with chronic illnesses who suffer from complications that can include kidney problems. According to a 2020 annual report from the US Kidney Data System, Taiwan, and Malaysia have the highest incidence of treated ESRD in the 45 to 65 age group and the 75 and over age group. Due to the increase in the number of patients, local government authorities have increased the number of dialysis centers provided by public or private funds. The prevalence of chronic kidney disease (CKD) and increased life expectancy will continue to drive the market demand for dialysis. Another factor influencing the market's growth is the expansion of health infrastructure in all countries. 

Supportive government initiatives and increased awareness of kidney disorders and their treatment modalities are also expected to drive the market during the forecast period. The evolution of technologically advanced dialysis equipment and kidney dialysis are vital factors impacting the dialysis market. Increased awareness of kidney problems and the types of treatments decreased complications. An increasing number of dialysis centers and hospitals in developing countries, combined with increasing patient treatments, is expected to drive the evolution of new dialysis equipment to drive the dialysis market during the forecast period.

MARKET RESTRAINTS:

Limited access to dialysis services among developing and underdeveloped countries is diluting the overall growth rate of the dialysis market. High costs associated with dialysis treatment are another notable factor hampering the market growth. Many patients in underdeveloped and developing countries do not have the financial capability to afford dialysis, which is limiting the adoption of dialysis services and hindering market growth. Technical challenges associated with dialysis machines and the lack of skilled professionals that can perform dialysis operations are further impeding the market growth. Alternative treatment options such as kidney transplantation procedures are reducing the demand for dialysis services and negatively resulting in market growth. Regulatory barriers and side effects associated with dialysis services are further showcasing a negative impact on the growth rate of the global dialysis market.  Factors such as limited or inadequate insurance coverage, lack of reliable infrastructure, such as stable electricity supply and clean water, and poor awareness levels among people regarding kidney diseases and dialysis services are further anticipated to impact the growth rate of the global dialysis market during the forecast period.

Impact of COVID-19 on the global dialysis market: 

The growing burden of acute kidney injury (AKI) associated with COVID-19 is increasing as the number of older people infected with the virus spreads. At the start of the pandemic, AKI's COVID-19 risk was estimated to be 2.3% to 9.1%. Currently, incidence rates have increased by over 18.5%, focusing on managing kidney failure in patients with COVID-19 plus respiratory failure. People on dialysis must visit clinics or hospitals 2-3 times a week, with concerns that patients may be infected with the coronavirus. With the spread of the COVID-19 virus, home dialysis devices are in more demand among patients. Hence, the growth rate of dialysis market is growing for the next few years. 

REPORT COVERAGE:

This research report on the global dialysis market has been segmented and sub-segmented based on type, dialysis, End-User, and region.

Global Dialysis Market - By Type: 

• Products 
• Services 

Based on the type, the services segment accounted for the largest share of the dialysis market. The segment growth is attributed to the increased focus on quality care delivery to patients by service providers and the establishment of well-equipped renal care facilities for chronic and acute treatment worldwide. Furthermore, service providers enhanced business models, which are patient-centric and profit-driven, are increasing the demand for services. In addition, increasing advancement in dialysis services and adding new features also promote segmental growth. 

 Global Dialysis Market - By Dialysis Type 

• Hemodialysis 
• Peritoneal Dialysis 

Based on the dialysis type, hemodialysis recorded significance and is predicted to continue its growth throughout the forecast period. Hemodialysis treatment uses an artificial kidney to replicate a healthy functioning kidney. 

However, inadequate peritoneal treatment training in developed and developing nations has limited the preference for peritoneal treatment. 

Global Dialysis Market - By End User 

• Dialysis Centers & Hospitals 
• Home Care 

Based on the end-user, the Dialysis treatment centers accounted for the largest market share in terms of value, which can be due to advantageous reimbursement offered by renal institutions and hospitals for renal therapies, a growing patient pool suffering from CKD and ESRD, and rising population healthcare spending. The increasing success rate of treatment through dialysis for kidney diseases demands segment growth. Additionally, the growing adoption of advanced devices and equipment for dialysis treatment also helps with segment growth. 

Due to the increasing manufacturing of homecare products and devices by the major key players, most people with mild kidney problems are taking the dialysis process home for their convenience leading to segmental growth.

Global Dialysis Market - By Region 

• North America 
• Europe 
• APAC 
• Latin America 
• Middle East and Africa 

Geographically, The North American dialysis market is anticipated to grow at a CAGR of 7.5% during the forecast period and is predicted to account for the most significant share of the global market during the forecast period. According to the statistics published by the National Institute of Diabetes and Digestive Kidney Diseases (NIDDH), approximately one in seven adults in America suffers from chronic kidney disease. As a result, 38 million Americans are suffering from this disease and are seeking dialysis treatment to increase their life span. The main reason for kidney diseases in America is people with high diabetes and blood pressure. Factors such as many patients and well-developed healthcare infrastructure are expected to generate good revenues in the region. Canada will also experience healthy growth in the CAGR due to the growing incidence of kidney diabetes and obesity. Increasing health policies for dialysis care in Canada is the primary reason for the market's growth. The government in Canada is investing in the development of dialysis devices to increase the success rate of treatment for patients with kidney failure. In addition, the boom in public health care spending in Canada should open a new development path for the Canadian dialysis market. 

The dialysis market in Europe is estimated to witness a prominent CAGR during the forecast period. In Europe, the German dialysis market is expected to grow by a CAGR of around 4.9%. In Germany, both dialyzes Germany dialysis are covered equally by statutory health insurance (SHI). The European market is expected to experience lucrative growth due to increased research spending, technological advancements, deteriorating human health, and the need for innovative and effective therapies. In addition, the increasing rate of kidney disease among the UK population is increasing the growth of the dialysis market in Europe. 

The dialysis market in APAC is predicted to register the fastest CAGR in the global market during the forecast period. The Asian region has the highest cases of end-stage renal diseases. China and India have universal dialysis coverage for their citizens. However, India holds the maximum market share due to the increasing number of programs on dialysis. In India, Pradhan Mantri National Dialysis Programme is part of the National Health Mission (NHM) to provide free dialysis services to the poor. Every year in India, nearly 2 lakh new cases are added to the end-stage renal disease list, resulting in the demand for dialysis in this region.

Additionally, increasing dialysis centers also boost the market’s growth rate. Increasing awareness about the dialysis process and the availability of nearby centers support the growth of the dialysis market. Peritoneal dialysis is China's most frequently performed dialysis to treat kidney diseases. Therefore, a training program has been conducted in the region to train healthcare professionals for the treatment without misleads. 

The dialysis market in the Middle East and Africa is estimated to account for a moderate global market share during the forecast period. The size of the South African dialysis market is expected to reach USD 2 billion by 2026. The increasing incidence of end-stage renal disease (ESRD) is expected to drive the market at a CAGR of 5% during the forecast period. In developing African countries, only 22% of patients receive dialysis treatment. 

Reimbursement is essential for the greater acceptability of dialysis due to the high cost of treatment. As a result, most patients in emerging countries in the MEA region either drop out of treatment midway or do not have access to treatment due to financial constraints. Supportive government initiatives will help develop the market in Latin America. The United Nations projects that the proportion of the Latin American population aged 65 and over will triple by the middle of the century, from 6.5% in 2005 to 21.5% in 2055. Brazil is expected to dominate the dialysis market in Latin America during the projected period. 

KEY MARKET PARTICIPANTS: 

Fresenius Medical Care AG & Co. KGaA, DaVita Healthcare Partners, Inc., 8. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Diaverum Healthcare Partners, Medtronic, Asahi Kasei Corporation, and Nipro Corporation are some of the promising companies in the global dialysis market. 

RECENT MARKET DEVELOPMENTS: 

• In 2022, A medical device company NewCo was formed by Medtronic and DaVita to improve the patient treatment experience and overall results. NewCo is focused on advancing the development of the new therapy for kidney failure patients and manufacturing home base products for kidney problem patients.  
• In 2021, Toyobo Co., Ltd. partnered with Nipro Corporation to build a new plant to produce artificial kidneys. 
• In 2021, Baxter International Inc. announced the launch of, the Sharesource Analytics 1.0 premium module, which is the next generation of digital health for home-based peritoneal dialysis (PD) patients.  
• In 2021, a home kidney care program was announced by DaVita Kidney Care to include the HomeChoice Claria Automated Peritoneal Dialysis (APD) system by Sharesource remote patient monitoring from Baxter International Inc. 
• In 2021, Fresenius Medical Care launched a new therapy named Kinexus™ Therapy Management Platform for home dialysis that supports the patient’s peritoneal dialysis therapy on the Liberty® Select cycler. 
• In 2021, Mar Cor (Cantel Medical Corporation) announced the launch of its innovative portable hemodialysis water system, EON. 
• In 2020, Fresenius Medical Care AG & Co. KGaA got approval from FDA and announced the launch of a PVC-free peritoneal dialysis solution bag designed for home dialysis called Biofine. 
• In 2020, Baxter International Inc. received FDA approval for the De Novo application of Theranova dilators designed to provide extended hemodialysis (HDx) therapy.